Pabatao, Isagani E.

HRN: 28-41-27  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/12/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
01/12/2026
01/19/2026
IV
500mg
Q8
Pneumoperitoneum Sec To PPUD
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Intra-abdominalProphylaxis    Compliance to guidelines: Compliant To Guidelines